These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10746706)

  • 1. Parkinson's pathology in a fly.
    Haass C; Kahle PJ
    Nature; 2000 Mar; 404(6776):341, 343. PubMed ID: 10746706
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of alpha-synuclein in Parkinson's disease: insights from animal models.
    Maries E; Dass B; Collier TJ; Kordower JH; Steece-Collier K
    Nat Rev Neurosci; 2003 Sep; 4(9):727-38. PubMed ID: 12951565
    [No Abstract]   [Full Text] [Related]  

  • 3. A Drosophila model of Parkinson's disease.
    Feany MB; Bender WW
    Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
    Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
    Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological prevention of Parkinson disease in Drosophila.
    Auluck PK; Bonini NM
    Nat Med; 2002 Nov; 8(11):1185-6. PubMed ID: 12411925
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease.
    Scherzer CR; Jensen RV; Gullans SR; Feany MB
    Hum Mol Genet; 2003 Oct; 12(19):2457-66. PubMed ID: 12915459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental models of Parkinson's disease.
    Beal MF
    Nat Rev Neurosci; 2001 May; 2(5):325-34. PubMed ID: 11331916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein in Parkinson's disease: light from two new angles.
    Golbe LI; Mouradian MM
    Ann Neurol; 2004 Feb; 55(2):153-6. PubMed ID: 14755715
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetics of Parkinson's disease.
    Lynch T; Farrer M; Hutton M; Hardy J
    Science; 1997 Nov; 278(5341):1212-3. PubMed ID: 9411743
    [No Abstract]   [Full Text] [Related]  

  • 10. Whole-mount analysis reveals normal numbers of dopaminergic neurons following misexpression of alpha-Synuclein in Drosophila.
    Pesah Y; Burgess H; Middlebrooks B; Ronningen K; Prosser J; Tirunagaru V; Zysk J; Mardon G
    Genesis; 2005 Apr; 41(4):154-9. PubMed ID: 15789427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiology. Of flies and mice.
    Dawson VL
    Science; 2000 Apr; 288(5466):631-2. PubMed ID: 10799001
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL; Przedborski S; Petrucelli L
    Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
    Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
    Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Synuclein locus triplication causes Parkinson's disease.
    Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
    Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171
    [No Abstract]   [Full Text] [Related]  

  • 16. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosology of Parkinson's disease: looking for the way out of a quagmire.
    Forman MS; Lee VM; Trojanowski JQ
    Neuron; 2005 Aug; 47(4):479-82. PubMed ID: 16102530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.
    Volles MJ; Lansbury PT
    Biochemistry; 2003 Jul; 42(26):7871-8. PubMed ID: 12834338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and Parkinson's disease: is the killer in the house?
    Chesselet MF
    Mol Psychiatry; 2003 Apr; 8(4):369-70. PubMed ID: 12740592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.